期刊文献+

丹参酮ⅡA磷脂复合物的制备及鉴别 被引量:4

Preparation and Identification of Tanshinone Ⅱ A Phospholipid Complex
下载PDF
导出
摘要 目的制备丹参酮ⅡA磷脂复合物并对复合物的形成进行验证。方法以丹参酮ⅡA与磷脂的复合率为评价标准,通过正交设计考察反应浓度、投料比例和反应温度对复合率的影响,并采用差式扫描量热分析(DSC)、X-射线衍射分析(X-ray)、红外分析法(IR)对所制得的复合物进行验证。结果确定了丹参酮ⅡA磷脂复合物的最佳制备工艺为:以乙酸乙酯为反应溶剂,反应温度为60℃,反应时间为2h,丹参酮ⅡA浓度为0.5mg/mL,丹参酮ⅡA与磷脂的投料比(摩尔比)为1∶1.5。差热扫描显示复合物的相变温度改变;X-射线衍射分析显示复合物呈现无定型特征;红外图谱发生变化。结论确定了制备丹参酮ⅡA磷脂复合物的最佳工艺,并且其磷脂复合物明显的改变了原药的理化性质。 ABSTRACT:OBJECTIVE To prepare tanshinone ⅡA-phospholipid complex and test the formation of phopholipid complex. METHODS The effects of the concentration of reactants,the ratio of reactants and the reactive temperature on preparation were investigated using orthogonal design,and the formation of complex was analyzed by using the differential scanning (DSC),X-ray diffraction analysis(X-ray)and infrared spectrum(IR).RESULTS The optimized conditions were obtained as follows:the solvent was ethyl acetate,the concentration of reactants was 0.5 mg/mL,the ratio of tanshinone ⅡA to phospho-lipid(molar)was 1∶1.5,the reactive temperature was 60 ℃ and the reactive was 2 h.The change of the transformation tem-perature was showed in DSC spectra.X-ray diffraction spectra indicated that the complex exhibits an amorphous characteristic. Infrared spectrum changed.CONCLUSION The best method to prepare tanshinone Ⅱ A-phospholipid complex is achieved, and its physic-chemical properties are significantly different from those of tanshinone ⅡA.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2015年第3期269-272,共4页 Journal of Nanjing University of Traditional Chinese Medicine
基金 江苏省中医药局科技项目(LZ13013)
关键词 丹参酮ⅡA 磷脂复合物 复合率 鉴别 丹参酮ⅡA Tanshinone ⅡA phospholipid complex complexing rate identification
  • 相关文献

参考文献7

  • 1Wang XJ, Wei YQ, Yuan SL, et al. Potential anticancer activity of tanshinone lI A against human breast cancer[J]. Intern JCancer, 2005, 116(5): 799-807.
  • 2Kim H H,Kim J H,Kwak HB, et al. Inhibition of osteoclast dif ferentiation and bone resorption by tanshinone n A isolated from Salviamiltiorrhiza Bunge[J]. Biochem Pharmacol, 2004: 1647-1656.
  • 3Lam BY, Lo AC, Sun X, et al. Neuroprotective effects of tan- shinones in transient focal cerebral ischemia in mice[J].Phy- tomed, 2003, 10(4): 286-291.
  • 4李素春,刘建平,曾昭征,郑逸轩.丹参酮ⅡA溶解渗透性以及常用辅料对其增溶促渗的研究[J].时珍国医国药,2008,19(7):1724-1726. 被引量:10
  • 5Hao HP, Wang GJ, Cui N, et al. Pharmacokinetics, absorption and tissue distribution of tanshinone II A solid[J]. Planta Med, 2006,1311-1317.
  • 6杨鸿波,邱国福,梁淑彩,何建社,许健,胡先明.银杏磷脂复合物复合率的测定[J].分析测试学报,2005,24(1):106-108. 被引量:10
  • 7刘嘉,刘汉清,李俊松,狄留庆.丹酚酸B磷脂复合物制备工艺研究[J].医药导报,2009,28(9):1189-1191. 被引量:5

二级参考文献27

  • 1BOMBARDELLI E.Phytosome:new cosmetic delivery syst-em[J].Boll Chim Farm,1991,130(11):431.
  • 2GIORGIO P,PIRGIORGIO A.Resveratrol-phospholipids co-mplexes,their preparation,and pharmaceutical and cosmetic composition containing same[P].United States Patent,20040116386A1.2004-06-17.
  • 3KIM C K,CHO Y J,GAO Z G.Preparation and evaluation of salvianolic acid B micro emulsions for oral delivery[J].J Control Rele,2001,70(1-2):149-155.
  • 4BHATTACHAR S N,HOWARD R J,TOMOO I,et al.The effects of complexation with hydrogenated phospholipid on the transport of salicylic acid,diclofenac and indomethacin across snake stratum corneum[J].Int J Pharm,1992,79(2):263.
  • 5中华人民共和国卫生部药典委员会.中华人民共和国药典:一部[M].北京:化学工业出版社,2000.257.
  • 6BOMBARD ELLI E, PATRI G. Complex compound of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them[P]. Europe Patent 0 275 005 A2. 1988 - 07 - 20.
  • 7GABETTA B, BOMBARDELLI E, PIFFER G. Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions[P]. Europe Patent 0 209 038 Al. 1987 - 01 - 21.
  • 8BOMBARD ELLI E, MAGISTRETTI M J. Pharmaceutical compositiond containing flavanolignanes and phospholipid as active principles[P]. Europe Patent 0 209 037 Al. 1987 - 01 - 21.
  • 9PIERLUIGI M, PAOLO S, CLAUDIO G, et al. Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteer dosed with Ginkgo biloba L. extracts[J]. Rapid Commun Mass Spectrum 2001, 15(12): 929- 934.
  • 10LOGGIA R D, SOSA S, TUBARO A, et al. Anti-inflammatory activity of some Ginkgo biloba constituents and of their phospholipid-complexes[J]. Fitoterapia, 1996, 67(3): 257-263.

共引文献22

同被引文献57

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部